Trends in Metabolic Bariatric Surgery Utilization in the Era of GLP-1s, 2022-2024
JAMA Surgery · 01.07.2026 · 161 (7) · 746
DOI: 10.1001/jamasurg.2026.1343 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Surgery, erschienen am 01.07.2026. Verfasst von Robert J Calzaretta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Analysis Group, Boston, Massachusetts and San Francisco, California. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This study examines trends in metabolic bariatric surgery utilization in the era of glucagon-like peptide-1 receptor agonists.
Autor:innen und Institutionen
- Analysis Group, Boston, Massachusetts and San Francisco, California.
- Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
- Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
- American College of Surgeons, Washington, DC.
Zitieren
APA
Calzaretta, R. J., Fink, S., Kothari, K., & Tsai, T. C. (2026). Trends in Metabolic Bariatric Surgery Utilization in the Era of GLP-1s, 2022-2024. JAMA Surgery, 161(7), 746. https://doi.org/10.1001/jamasurg.2026.1343
Vancouver
Calzaretta RJ, Fink S, Kothari K, Tsai TC. Trends in Metabolic Bariatric Surgery Utilization in the Era of GLP-1s, 2022-2024. JAMA Surgery. 2026;161(7):746. doi:10.1001/jamasurg.2026.1343
BibTeX
@article{Calzaretta2026,
author = {Calzaretta, Robert J and Fink, Stephen and Kothari, Kabir and Tsai, Thomas C},
title = {Trends in Metabolic Bariatric Surgery Utilization in the Era of GLP-1s, 2022-2024},
journal = {JAMA Surgery},
year = {2026},
volume = {161},
number = {7},
pages = {746},
doi = {10.1001/jamasurg.2026.1343}
}
EUVIMED